Micro-mobile Foot Compression and Diabetic Foot

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

September 9, 2018

Study Completion Date

May 14, 2021

Conditions
DiabetesPADLower Extremity EdemaNeuropathy;PeripheralFoot Ulcer, DiabeticLymphatic Diseases
Interventions
DEVICE

Avex Footbeat

Subjects will receive diabetic shoes equipped with Boa Technology shoelace system and Footbeat compression insoles, which for simplicity will be named intervention shoes. All participants will be asked to wear the intervention shoes for duration of 4-weeks on daily basis (minimum 4 hours per day). Daily use of the intervention shoes will be assumed to improve balance, mobility, plantar sensation, lower extremity edema, and lower extremity skin perfusion.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Avex LLC

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot | Biotech Hunter | Biotech Hunter